Omega-3 Fatty Acids in Health and Disease: Part 2—Health Effects of Omega-3 Fatty Acids in Autoimmune Diseases, Mental Health, and Gene Expression

2005 ◽  
Vol 8 (2) ◽  
pp. 133-148 ◽  
Author(s):  
Fereidoon Shahidi ◽  
Homan Miraliakbari
BMC Medicine ◽  
2013 ◽  
Vol 11 (1) ◽  
Author(s):  
Michel de Lorgeril ◽  
Patricia Salen ◽  
Pascal Defaye ◽  
Mikael Rabaeus

Nutrients ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 3765
Author(s):  
Virginie Bottero ◽  
Judith A. Potashkin

Background: The Mediterranean diet, which is rich in olive oil, nuts, and fish, is considered healthy and may reduce the risk of chronic diseases. Methods: Here, we compared the transcriptome from the blood of subjects with diets supplemented with olives, nuts, or long-chain omega-3 fatty acids and identified the genes differentially expressed. The dietary genes obtained were subjected to network analysis to determine the main pathways, as well as the transcription factors and microRNA interaction networks to elucidate their regulation. Finally, a gene-associated disease interaction network was performed. Results: We identified several genes whose expression is altered after the intake of components of the Mediterranean diets compared to controls. These genes were associated with infection and inflammation. Transcription factors and miRNAs were identified as potential regulators of the dietary genes. Interestingly, caspase 1 and sialophorin are differentially expressed in the opposite direction after the intake of supplements compared to Alzheimer’s disease patients. In addition, ten transcription factors were identified that regulated gene expression in supplemented diets, mild cognitive impairment, and Alzheimer’s disease. Conclusions: We identified genes whose expression is altered after the intake of the supplements as well as the transcription factors and miRNAs involved in their regulation. These genes are associated with schizophrenia, neoplasms, and rheumatic arthritis, suggesting that the Mediterranean diet may be beneficial in reducing these diseases. In addition, the results suggest that the Mediterranean diet may also be beneficial in reducing the risk of dementia.


2020 ◽  
Vol 4 (1) ◽  
pp. 18-30 ◽  
Author(s):  
Klaus W. Lange

2017 ◽  
Vol 49 (06) ◽  
pp. 446-451 ◽  
Author(s):  
Khadijeh Nasri ◽  
Sedigheh Hantoushzadeh ◽  
Esmat Aghadavod ◽  
Mohsen Taghizadeh ◽  
Zatollah Asemi

AbstractLimited data are available evaluating the effects of omega-3 fatty acids supplementation on gene expression involved in the insulin and lipid-signaling pathway in women with polycystic ovary syndrome (PCOS). This study was conducted to evaluate the effects of omega-3 fatty acids supplementation on gene expression involved in the insulin and lipid signaling pathway in women with PCOS. This randomized double blind, placebo-controlled trial was done among 60 women aged 18–40 years old and diagnosed with PCOS according to the Rotterdam criteria. Participants were randomly assigned into 2 groups to receive either 1 000 mg omega-3 fatty acids from flaxseed oil containing 400 mg α-linolenic acid (n=30) or placebo (n=30) twice a day for 12 weeks. Gene expressions involved in the insulin and lipid-signaling pathway were quantified in blood samples of PCOS women with RT-PCR method. Quantitative results of RT-PCR demonstrated that compared with the placebo, omega-3 fatty acids supplementation upregulated peroxisome proliferator-activated receptor gamma (PPAR-γ) mRNA (p=0.005) in peripheral blood mononuclear cells of women with PCOS. In addition, compared to the placebo, omega-3 fatty acids supplementation downregulated expressed levels of oxidized low-density lipoprotein receptor (LDLR) mRNA (p=0.002) in peripheral blood mononuclear cells of women with PCOS. We did not observe any significant effect of omega-3 fatty acids supplementation on expressed levels of glucose transporter 1 (GLUT-1) and lipoprotein(a) [Lp(a)] genes in peripheral blood mononuclear cells. Overall, omega-3 fatty acids supplementation for 12 weeks in PCOS women significantly improved gene expression of PPAR-γ and LDLR.


2006 ◽  
Vol 188 (2) ◽  
pp. 109-121 ◽  
Author(s):  
Ursula Werneke ◽  
Trevor Turner ◽  
Stefan Priebe

BackgroundThe use of complementary medicines in those with mental health problems is well documented. However, their effectiveness is often not established and they may be less harmless than commonly assumed.AimsTo review the complementary medicines routinely encountered in psychiatric practice, their effectiveness, potential adverse effects and interactions.MethodElectronic and manual literature search on the effectiveness and safety of psychotropic complementary medicines.ResultsPotentially useful substances include ginkgo and hydergine as cognitive enhancers, passion flower and valerian as sedatives, St John's wort and sadenosylmethionine as antidepressants, and selenium and folate to complement antidepressants. The evidence is less conclusive for the use of omega-3 fatty acids as augmentation treatment in schizophrenia, melatonin for tardive dyskinesia and 18-methoxycoronaridine, an ibogaine derivative, for the treatment of cocaine and heroin addiction.ConclusionsSystematic clinical trials are needed to test promising substances. Meanwhile, those wishing to take psychotropic complementary medicines require appropriate advice.


2015 ◽  
Vol 67 (2) ◽  
pp. 370-375 ◽  
Author(s):  
Neda Gholamian Dehkordi ◽  
Maryam Noorbakhshnia ◽  
Kamran Ghaedi ◽  
Abolghasem Esmaeili ◽  
Mohammad Dabaghi

Sign in / Sign up

Export Citation Format

Share Document